Page last updated: 2024-08-25

zoledronic acid and Recrudescence

zoledronic acid has been researched along with Recrudescence in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (25.71)	29.6817
2010's	23 (65.71)	24.3611
2020's	3 (8.57)	2.80

Authors

Authors	Studies
Chen, S; Li, C; Li, H; Wang, R; Wang, Y; Yue, L	1
Chen, TS; Hsu, YC; Kao, FC; Liu, PH; Tu, YK	1
Aikeremu, D; Alimasi, W; Liu, Y; Lu, L; Nazierhan, S; Niyazi, W; Sun, Z; Wang, H; Xu, K	1
Cheng, AY; Huang, ZF; Shi, C; Zhang, M	1
Li, M; Lu, Y; Mao, C; Wan, P; Wang, W; Yang, K; Zhang, Y; Zhu, Y	1
Ito, E; Kobayashi, A; Kudo, K; Tanaka, T; Terui, K	1
Cai, Q; Xu, X; Zhang, J; Zhang, T; Zhao, D	1
Li, CW; Liang, BC; Liu, K; Liu, Z; Mao, YF; Shi, XL; Wu, LG	1
Kaneko, M; Murata, T; Yamada, T; Yoshino, H	1
Bakhous, A; Waheed, S; Zhu, H	1
Abiko, M; Harada, M; Sato, T; Shiono, S; Takanashi, I	1
Beck, JT; Bilic, S; Isaacs, R; Iyer, SP; Kelly, KR; Munshi, NC; Sen, S; Shah, J; Stewart, AK	1
Hagelauer, N; Pabst, AM; Walter, C; Ziebart, T	1
Arita, K; Hiranuma, S; Kuramochi, J; Kurokawa, T; Matsumoto, A; Sanada, K; Takiguchi, N; Tanaka, Y; Usui, S	1
Grasko, JM; Herrmann, RP; Vasikaran, SD	1
Bamias, A; Dimopoulos, MA; Mavrikakis, M; Mountzios, G; Papadimitriou, C; Papadopoulos, G; Syrigos, K; Terpos, E	1
de Jong, E; Hamdy, NA; Kuijpers, SC; van Merkesteyn, JP	1
Friese, K; Genss, EM; Heinrigs, M; Janni, W; Jückstock, J; Rack, B; Rammel, G; Schindlbeck, C; Schoberth, A; Sommer, H; Strobl, B; Zwingers, T	1
Cagli, B; Intagliata, S; Onetti Muda, A; Perrone, G; Persichetti, P; Santini, D; Segreto, F; Tonini, G	1
Hollstein, S; Hölzle, F; Kriwalsky, MS; Kunkel, M; Maurer, P; Rashad, A; Sandulescu, T; Stricker, I	1
Brown, JP; Bucci-Rechtweg, C; Cafoncelli, S; del Pino-Montes, J; Fraser, WD; Hosking, DJ; Lyles, K; Miller, PD; Reid, IR; Su, G; Walsh, JP	1
Furukawa, N; Haruta, S; Kawaguchi, R; Kobayashi, H; Nagai, A; Ooi, H; Shigemitsu, A; Tanase, Y; Yamada, Y; Yoshida, S	1
Hewson, ID	1
Arora, B; Arun Kurkure, P; Jalali, R; Medhi, S; Rangarajan, V; Sondhi, V; Sridhar, E	1
Furukawa, K; Hosaka, M; Ishida, J; Matsushima, Y; Saito, M	1
Huang, C; Huang, WW; Lin, L; Liu, J; Zheng, HY	1
Berenson, JR	1
Suzuki, K	1
Bartsch, R; Hussian, D; Locker, GJ; Pluschnig, U; Sevelda, U; Steger, GG; Wenzel, C; Zielinski, CC	1
Corradi, D; Manfredi, M; Meleti, M; Merigo, E; Vescovi, P	1
Anagnostopoulos, A; Chantry, A; Croucher, PI; Dimopoulos, MA; Heath, DJ; Katodritou, E; Pouli, A; Rahemtulla, A; Terpos, E; Verrou, E; Vervessou, EC; Zervas, K	1
Alpay, N; Ayer, M; Küçükkaya, RD; Mete, O; Nalçaci, M; Yavuz, AS; Yenerel, MN; Yildirim, ND	1
Bellomi, M; Bruschini, R; Cossu Rocca, M; Goldhirsch, A; Nole, F; Preda, L; Sanna, G; Verri, E	1
Birbilis, T; Gymnopoulou, E; Oikonomou, A; Prassopoulos, P	1
Lortholary, A	1

Reviews

3 review(s) available for zoledronic acid and Recrudescence

Article	Year
Zoledronic acid as an adjuvant therapy in patients with breast cancer: a systematic review and meta-analysis. PloS one, 2012, Volume: 7, Issue:7 Topics: Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Humans; Imidazoles; Recurrence; Treatment Outcome; Zoledronic Acid	2012
Current therapeutic strategy for multiple myeloma. Japanese journal of clinical oncology, 2013, Volume: 43, Issue:2 Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Density Conservation Agents; Boronic Acids; Bortezomib; Clinical Trials as Topic; Creatinine; Cyclophosphamide; Denosumab; Dexamethasone; Diphosphonates; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Immunoglobulins; Kidney; Lenalidomide; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Melphalan; Molecular Targeted Therapy; Multiple Myeloma; Neoplasms, Second Primary; Precision Medicine; Prednisolone; Pyrazines; Quality of Life; Recurrence; Remission Induction; Survival Rate; Thalidomide; Zoledronic Acid	2013
[Tumor-induced hypercalcemia. Review of bisphosphonate treatment]. La Revue de medecine interne, 2001, Volume: 22, Issue:7 Topics: Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Etidronic Acid; Fluid Therapy; Hematologic Neoplasms; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pamidronate; Prognosis; Recurrence; Sodium Chloride; Treatment Outcome; Zoledronic Acid	2001

Trials

4 trial(s) available for zoledronic acid and Recrudescence

Article	Year
Zoledronic acid combined with percutaneous kyphoplasty in the treatment of osteoporotic compression fracture in a single T12 or L1 vertebral body in postmenopausal women. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2019, Volume: 30, Issue:7 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Combined Modality Therapy; Female; Fractures, Compression; Humans; Kyphoplasty; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Prospective Studies; Recurrence; Spinal Fractures; Thoracic Vertebrae; Zoledronic Acid	2019
Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures. Orthopaedic surgery, 2019, Volume: 11, Issue:3 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Drug Administration Schedule; Female; Follow-Up Studies; Fracture Fixation, Intramedullary; Hip Fractures; Humans; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Postoperative Care; Recurrence; Secondary Prevention; Treatment Outcome; Zoledronic Acid	2019
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events. British journal of haematology, 2014, Volume: 167, Issue:3 Topics: Aged; Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Drug Therapy, Combination; Female; Fractures, Spontaneous; Humans; Hypertension; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; Maximum Tolerated Dose; Middle Aged; Molecular Targeted Therapy; Multiple Myeloma; Neoplasm Proteins; Osteolysis; Recurrence; Spinal Cord Compression; Zoledronic Acid	2014
Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer. Anticancer research, 2010, Volume: 30, Issue:5 Topics: Adult; Aged; Bone Density Conservation Agents; Bone Marrow; Bone Marrow Cells; Breast Neoplasms; Cell Cycle; Chemotherapy, Adjuvant; Diphosphonates; Disease-Free Survival; Female; Humans; Imidazoles; Middle Aged; Models, Statistical; Recurrence; Zoledronic Acid	2010

Other Studies

28 other study(ies) available for zoledronic acid and Recrudescence

Article	Year
Effects of rosuvastatin and zoledronic acid in combination on the recovery of senile osteoporotic vertebral compression fracture following percutaneous vertebroplasty. The Journal of international medical research, 2020, Volume: 48, Issue:5 Topics: Age Factors; Aged; Aged, 80 and over; Aging; Bone Density; Case-Control Studies; Drug Therapy, Combination; Female; Fractures, Compression; Functional Status; Humans; Male; Middle Aged; Osteoporotic Fractures; Pain Management; Pain, Postoperative; Recurrence; Retrospective Studies; Rosuvastatin Calcium; Spinal Fractures; Treatment Outcome; Vertebroplasty; Zoledronic Acid	2020
Effects of Injected Antiosteoporotic Medication Versus Oral Bisphosphonates on Rates of Repeated Vertebroplasty or Kyphoplasty. Clinical therapeutics, 2020, Volume: 42, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Density Conservation Agents; Denosumab; Drug Therapy, Combination; Female; Fractures, Compression; Humans; Ibandronic Acid; Injections; Male; Middle Aged; Recurrence; Reoperation; Teriparatide; Vertebroplasty; Zoledronic Acid	2020
Expression changes of IL-17 in zoledronic acid combined with PVP technology in the treatment of postmenopausal osteoporotic vertebral compression fracture and its predictive value of relapse. Journal of musculoskeletal & neuronal interactions, 2020, 12-01, Volume: 20, Issue:4 Topics: Aged; Biomarkers; Bone Density Conservation Agents; Female; Fractures, Compression; Humans; Infusions, Intravenous; Interleukin-17; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Recurrence; Spinal Fractures; Treatment Outcome; Vertebroplasty; Zoledronic Acid	2020
Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly. Clinical interventions in aging, 2018, Volume: 13 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Combined Modality Therapy; Diphosphonates; Female; Fractures, Compression; Humans; Imidazoles; Infusions, Intravenous; Kyphoplasty; Lumbar Vertebrae; Male; Osteoporotic Fractures; Radiography; Recurrence; Retrospective Studies; Spinal Fractures; Thoracic Vertebrae; Vertebroplasty; Zoledronic Acid	2018
Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone. Acta biomaterialia, 2018, 09-01, Volume: 77 Topics: Alloys; Apoptosis; Biocompatible Materials; Bone and Bones; Bone Neoplasms; Calcium Phosphates; Cell Movement; Cytoskeleton; Diphosphonates; Giant Cell Tumor of Bone; Humans; Magnesium; Mitochondria; Neoplasm Metastasis; Neoplasms; NF-kappa B; Osteoclasts; Osteolysis; Oxidative Stress; Recurrence; Risk Factors; Signal Transduction; Strontium; Zoledronic Acid	2018
Zoledronic acid for relapsed Langerhans cell histiocytosis with isolated skull bone lesion. Pediatrics international : official journal of the Japan Pediatric Society, 2019, Volume: 61, Issue:3 Topics: Biomarkers; Bone Density Conservation Agents; Bone Diseases; Child; Female; Histiocytosis, Langerhans-Cell; Humans; Magnetic Resonance Imaging; Recurrence; Skull; Zoledronic Acid	2019
[A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Combinations; Female; Humans; Imidazoles; Oxonic Acid; Recurrence; Tegafur; Zoledronic Acid	2013
Waldeström macroglobulinaemia relapsing with focal bone disease and achieving major response with single-agent zoledronic acid. British journal of haematology, 2013, Volume: 163, Issue:3 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Resorption; Boronic Acids; Bortezomib; Combined Modality Therapy; Dexamethasone; Diphosphonates; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Male; Melphalan; Middle Aged; Multimodal Imaging; Osteolysis; Positron-Emission Tomography; Pyrazines; Recurrence; Remission Induction; Rituximab; Tomography, X-Ray Computed; Waldenstrom Macroglobulinemia; Zoledronic Acid	2013
[A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:6 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Lung Neoplasms; Male; Recurrence; Tegafur; Time Factors; Treatment Outcome; Uracil; Zoledronic Acid	2014
Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation. Clinical oral investigations, 2015, Volume: 19, Issue:5 Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cell Movement; Cell Survival; Cells, Cultured; Cyclohexenes; Diphosphonates; Diterpenes; Endothelial Cells; Eugenol; Farnesol; Fibroblasts; Humans; Imidazoles; Limonene; Menthol; Osteogenesis; Protein Prenylation; Recurrence; Squalene; Terpenes; Umbilical Veins; Zoledronic Acid	2015
[A case of recurrent breast carcinoma metastasis successfully treated with S-1 and zoledronic acid therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Diphosphonates; Drug Combinations; Female; Humans; Imidazoles; Magnetic Resonance Imaging; Neoplasm Metastasis; Oxonic Acid; Recurrence; Tegafur; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid	2009
Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2009, Volume: 67, Issue:3 Topics: Bone Density Conservation Agents; Cross Infection; Diphosphonates; Escherichia coli Infections; Fatal Outcome; Femoral Fractures; Fractures, Spontaneous; Humans; Imidazoles; Injections, Intravenous; Male; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Osteopetrosis; Recurrence; Zoledronic Acid	2009
Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid. Translational research : the journal of laboratory and clinical medicine, 2010, Volume: 155, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Diphosphonates; Disease-Free Survival; Female; Humans; Imidazoles; Male; Middle Aged; Recurrence; Spinal Neoplasms; Zoledronic Acid	2010
Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2011, Volume: 39, Issue:1 Topics: Adult; Aged; Analgesics; Bone Density Conservation Agents; Child; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Male; Mandibular Diseases; Middle Aged; Osteomyelitis; Pamidronate; Radionuclide Imaging; Recurrence; Sclerosis; Treatment Outcome; Young Adult; Zoledronic Acid	2011
Recurrent scrotal hemangiomas during treatment with sunitinib. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Dec-10, Volume: 28, Issue:35 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Genital Neoplasms, Male; Hemangioma; Humans; Imidazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Recurrence; Scrotum; Skin Neoplasms; Sunitinib; Zoledronic Acid	2010
Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris. International journal of oral and maxillofacial surgery, 2011, Volume: 40, Issue:3 Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bone Density Conservation Agents; Carcinoma; Chronic Disease; Debridement; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Male; Maxillary Diseases; Maxillary Sinusitis; Middle Aged; Osteonecrosis; Osteoporosis; Osteotomy; Recurrence; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid	2011
A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2011, Volume: 26, Issue:9 Topics: Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Kaplan-Meier Estimate; Osteitis Deformans; Quality of Life; Radionuclide Imaging; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Treatment Outcome; Zoledronic Acid	2011
[A case of recurrent endometrial cancer metastasis successfully treated with zoledronic Acid]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:6 Topics: Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Endometrial Neoplasms; Fatal Outcome; Female; Humans; Imidazoles; Magnetic Resonance Imaging; Middle Aged; Recurrence; Tomography, X-Ray Computed; Zoledronic Acid	2011
Bisphosphonate-associated osteonecrosis of the jaw: a six-year history of a case. The New Zealand dental journal, 2011, Volume: 107, Issue:3 Topics: Bone Density Conservation Agents; Debridement; Diphosphonates; Disease Progression; Follow-Up Studies; Humans; Imidazoles; Immunoglobulin kappa-Chains; Male; Mandibular Diseases; Mandibular Neoplasms; Middle Aged; Multiple Myeloma; Osteonecrosis; Recurrence; Zoledronic Acid	2011
Complete remission and long-term survival in a child with relapsed medulloblastoma with extensive osteosclerotic bony metastasis with a novel metronomic chemobiological approach. Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:5 Topics: Adolescent; Bone Neoplasms; Brain Neoplasms; Diphosphonates; Humans; Imidazoles; Male; Medulloblastoma; Osteosclerosis; Recurrence; Zoledronic Acid	2012
Efficacy of vinorelbine and zoledronate combination therapy against postoperative recurrence of lung cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Lung Neoplasms; Male; Neoplasm Staging; Recurrence; Vinblastine; Vinorelbine; Zoledronic Acid	2012
Updates in the treatment of multiple myeloma. Clinical advances in hematology & oncology : H&O, 2012, Volume: 10, Issue:10 Topics: Antibodies, Monoclonal; Antineoplastic Agents; B-Cell Maturation Antigen; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Disease Management; Humans; Imidazoles; Killer Cells, Natural; Multiple Myeloma; Proteasome Inhibitors; Quality of Life; Recurrence; Survival Analysis; T-Lymphocytes; Zoledronic Acid	2012
Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:9 Topics: Bone Resorption; Breast Neoplasms; Diphosphonates; Drug Resistance; Female; Humans; Hypercalcemia; Imidazoles; Liver Neoplasms; Middle Aged; Neoplasm Metastasis; Pamidronate; Quality of Life; Recurrence; Zoledronic Acid	2004
Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2005, Volume: 34, Issue:10 Topics: Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Bone Neoplasms; Curettage; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Mandibular Diseases; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Recurrence; Zoledronic Acid	2005
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma. British journal of haematology, 2006, Volume: 135, Issue:5 Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone Remodeling; Boronic Acids; Bortezomib; Case-Control Studies; Collagen Type I; Diphosphonates; Female; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Isoenzymes; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Osteoprotegerin; Peptides; Protease Inhibitors; Pyrazines; RANK Ligand; Recurrence; Statistics, Nonparametric; Tartrate-Resistant Acid Phosphatase; Zoledronic Acid	2006
Leukocytoclastic vasculitis due to thalidomide in multiple myeloma. Japanese journal of clinical oncology, 2007, Volume: 37, Issue:9 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Male; Middle Aged; Multiple Myeloma; Recurrence; Thalidomide; Vasculitis, Leukocytoclastic, Cutaneous; Zoledronic Acid	2007
The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates. Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:3 Topics: Adenocarcinoma; Bone Neoplasms; Bone Plates; Bone Screws; Breast Neoplasms; Cutaneous Fistula; Diphosphonates; Female; Humans; Imidazoles; Male; Mandible; Mandibular Diseases; Middle Aged; Necrosis; Oral Fistula; Osteolysis; Osteomyelitis; Pamidronate; Prostatic Neoplasms; Recurrence; Tomography, X-Ray Computed; Zoledronic Acid	2008
Paget disease of the spine manifested by thoracic and lumbar epidural lipomatosis: magnetic resonance imaging findings. Spine, 2007, Dec-01, Volume: 32, Issue:25 Topics: Bone Density Conservation Agents; Decompression, Surgical; Diphosphonates; Disease Progression; Epidural Space; Humans; Imidazoles; Laminectomy; Lipomatosis; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteitis Deformans; Paraparesis; Recurrence; Spinal Diseases; Spinal Stenosis; Thoracic Vertebrae; Treatment Outcome; Zoledronic Acid	2007